| Abstrakt: |
A researcher from Bashkir State Medical University in Ufa, Russia has published findings on the prospects of using immunotherapy for breast cancer treatment. The study explores the use of microRNAs and transposable elements as objects for immunotherapy. The research suggests that epigenetic activation of retroelements, along with the use of inhibitors, could stimulate an immune response against tumor cells. Additionally, specific transposon-derived microRNAs were identified as potential guides for targeted therapy. The study also discusses the potential use of endogenous retroviruses and LINE1 retrotransposons as diagnostic biomarkers for breast cancer. [Extracted from the article] |
